428 related articles for article (PubMed ID: 11950912)
1. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas.
Shukuwa T; Katayama I; Koji T
Mod Pathol; 2002 Apr; 15(4):387-96. PubMed ID: 11950912
[TBL] [Abstract][Full Text] [Related]
2. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
3. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
4. [The relationship between Fas/FasL and proliferating cell nuclear antigen expression and malignant degree in human melanoma].
Wang YC; Tan Y
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):965-8. PubMed ID: 18756968
[TBL] [Abstract][Full Text] [Related]
5. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
7. FAS, FAS ligand, tumor infiltrating lymphocytes, and macrophages in malignant melanoma: an immunohistochemical study.
Bozdogan N; Bozdogan O; Pak I; Atasoy P
Int J Dermatol; 2010 Jul; 49(7):761-7. PubMed ID: 20618494
[TBL] [Abstract][Full Text] [Related]
8. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
[TBL] [Abstract][Full Text] [Related]
9. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
11. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
12. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
Satchell AC; Barnetson RS; Halliday GM
Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
[TBL] [Abstract][Full Text] [Related]
13. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
15. Fas/Fas ligand system and apoptosis induction in testicular carcinoma.
Schmelz HU; Abend M; Kraft K; Hauck EW; Weidner W; Van Beuningen D; Sparwasser C
Cancer; 2002 Jul; 95(1):73-81. PubMed ID: 12115319
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
Hamzaoui A; Ammar J; Graïri H; Hamzaoui K
Mediators Inflamm; 2003 Aug; 12(4):209-14. PubMed ID: 14514471
[TBL] [Abstract][Full Text] [Related]
18. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
[TBL] [Abstract][Full Text] [Related]
19. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.
Sugiura T; Murakawa Y; Nagai A; Kondo M; Kobayashi S
Arthritis Rheum; 1999 Feb; 42(2):291-8. PubMed ID: 10025923
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]